These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19478144)

  • 1. Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase.
    Ussher JR; Koves TR; Jaswal JS; Zhang L; Ilkayeva O; Dyck JR; Muoio DM; Lopaschuk GD
    Diabetes; 2009 Aug; 58(8):1766-75. PubMed ID: 19478144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
    Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
    Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase.
    Campbell FM; Kozak R; Wagner A; Altarejos JY; Dyck JR; Belke DD; Severson DL; Kelly DP; Lopaschuk GD
    J Biol Chem; 2002 Feb; 277(6):4098-103. PubMed ID: 11734553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart.
    Sakamoto J; Barr RL; Kavanagh KM; Lopaschuk GD
    Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1196-204. PubMed ID: 10749714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebroventricular leptin administration differentially alters cardiac energy metabolism in mice fed a low-fat and high-fat diet.
    Keung W; Cadete VJ; Palaniyappan A; Jablonski A; Fischer M; Lopaschuk GD
    J Cardiovasc Pharmacol; 2011 Jan; 57(1):103-13. PubMed ID: 20980918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury.
    Dyck JR; Hopkins TA; Bonnet S; Michelakis ED; Young ME; Watanabe M; Kawase Y; Jishage K; Lopaschuk GD
    Circulation; 2006 Oct; 114(16):1721-8. PubMed ID: 17030679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.
    Koves TR; Ussher JR; Noland RC; Slentz D; Mosedale M; Ilkayeva O; Bain J; Stevens R; Dyck JR; Newgard CB; Lopaschuk GD; Muoio DM
    Cell Metab; 2008 Jan; 7(1):45-56. PubMed ID: 18177724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity.
    Aksentijević D; McAndrew DJ; Karlstädt A; Zervou S; Sebag-Montefiore L; Cross R; Douglas G; Regitz-Zagrosek V; Lopaschuk GD; Neubauer S; Lygate CA
    J Mol Cell Cardiol; 2014 Oct; 75():76-87. PubMed ID: 25066696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling.
    Alrob OA; Sankaralingam S; Ma C; Wagg CS; Fillmore N; Jaswal JS; Sack MN; Lehner R; Gupta MP; Michelakis ED; Padwal RS; Johnstone DE; Sharma AM; Lopaschuk GD
    Cardiovasc Res; 2014 Sep; 103(4):485-97. PubMed ID: 24966184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac diacylglycerol accumulation in high fat-fed mice is associated with impaired insulin-stimulated glucose oxidation.
    Zhang L; Ussher JR; Oka T; Cadete VJ; Wagg C; Lopaschuk GD
    Cardiovasc Res; 2011 Jan; 89(1):148-56. PubMed ID: 20729341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of serine palmitoyl transferase I reduces cardiac ceramide levels and increases glycolysis rates following diet-induced insulin resistance.
    Ussher JR; Folmes CD; Keung W; Fillmore N; Jaswal JS; Cadete VJ; Beker DL; Lam VH; Zhang L; Lopaschuk GD
    PLoS One; 2012; 7(5):e37703. PubMed ID: 22629445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding.
    Wright JJ; Kim J; Buchanan J; Boudina S; Sena S; Bakirtzi K; Ilkun O; Theobald HA; Cooksey RC; Kandror KV; Abel ED
    Cardiovasc Res; 2009 May; 82(2):351-60. PubMed ID: 19147655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of a modified human malonyl-CoA decarboxylase blocks the glucose-induced increase in malonyl-CoA level but has no impact on insulin secretion in INS-1-derived (832/13) beta-cells.
    Mulder H; Lu D; Finley J; An J; Cohen J; Antinozzi PA; McGarry JD; Newgard CB
    J Biol Chem; 2001 Mar; 276(9):6479-84. PubMed ID: 11113153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical-genetic induction of Malonyl-CoA decarboxylase in skeletal muscle.
    Rodriguez S; Ellis JM; Wolfgang MJ
    BMC Biochem; 2014 Aug; 15():20. PubMed ID: 25152047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac-specific adipose triglyceride lipase overexpression protects from cardiac steatosis and dilated cardiomyopathy following diet-induced obesity.
    Pulinilkunnil T; Kienesberger PC; Nagendran J; Sharma N; Young ME; Dyck JR
    Int J Obes (Lond); 2014 Feb; 38(2):205-15. PubMed ID: 23817015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCD encodes peroxisomal and cytoplasmic forms of malonyl-CoA decarboxylase and is mutated in malonyl-CoA decarboxylase deficiency.
    Sacksteder KA; Morrell JC; Wanders RJ; Matalon R; Gould SJ
    J Biol Chem; 1999 Aug; 274(35):24461-8. PubMed ID: 10455107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism.
    Dyck JR; Berthiaume LG; Thomas PD; Kantor PF; Barr AJ; Barr R; Singh D; Hopkins TA; Voilley N; Prentki M; Lopaschuk GD
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):599-608. PubMed ID: 10947976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malonyl-CoA decarboxylase inhibition as a novel approach to treat ischemic heart disease.
    Lopaschuk GD; Stanley WC
    Cardiovasc Drugs Ther; 2006 Dec; 20(6):433-9. PubMed ID: 17136490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of malonyl-CoA decarboxylase reduces the inflammatory response associated with insulin resistance.
    Samokhvalov V; Ussher JR; Fillmore N; Armstrong IK; Keung W; Moroz D; Lopaschuk DG; Seubert J; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2012 Dec; 303(12):E1459-68. PubMed ID: 23074239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury.
    Ussher JR; Wang W; Gandhi M; Keung W; Samokhvalov V; Oka T; Wagg CS; Jaswal JS; Harris RA; Clanachan AS; Dyck JR; Lopaschuk GD
    Cardiovasc Res; 2012 May; 94(2):359-69. PubMed ID: 22436846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.